LOADING
Comparing Eli Lilly and Company (LLY) and Mastercard Inc (MA) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | MA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $905.8B | $432.9B |
| P/E Ratio | 35.2 | 28.3 |
| Forward P/E | 26.3 | 25.3 |
| PEG Ratio | 1.28 | 1.58 |
| EPS | $28.85 | $17.29 |
| Revenue Growth (YoY) | 55.5% | 15.8% |
| Profit Margin | 35.0% | 45.9% |
| Return on Equity | 107.5% | 232.1% |
| Dividend Yield | 0.63% | 0.66% |
| Beta | 0.48 | 0.76 |
| 52-Week High | $1,132.06 | $599.05 |
| 52-Week Low | $620.46 | $479.68 |
| Volume | -- | -- |
Eli Lilly and Company is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Mastercard Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.